Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment

NCT01235949 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

850

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL: GSK1024850A (SynflorixTM)
BIOLOGICAL: Infanrix hexa
BIOLOGICAL: Infanrix-IPV/Hib
DRUG: Ibuprofen
DRUG: Paracetamol

Sponsor

GlaxoSmithKline